Relapsing Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Relapsing Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Participants With Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis [Phase 4]
This Phase 4 clinical trial is evaluating the efficacy, safety, pharmacokinetics, and pharmacodynamics of ocrelizumab in participants with R…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab [Phase 3]
Phase 3 clinical trial evaluating pharmacokinetics, pharmacodynamics, safety and tolerability of a new maintenance dosing regimen of ofatumu…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS) [Phase 2]
A Phase 2 pharmacokinetics/pharmacodynamics and safety/tolerability trial of Fenebrutinib in children and adolescents with Relapsing Multipl…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis [Phase 3]
Extension study of ublituximab in relapsing multiple sclerosis is a Phase 3 trial that is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk
A clinical trial is assessing whether BRIUMVI (ublituximab) is present in breast milk and at what concentration, to evaluate potential expos…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
This clinical trial update summarizes the real-world experience of participants treated with BRIUMVI (ublituximab-xiiy) for Relapsing Multip…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis. [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of Remibrutinib after switching from Ocrelizumab in people with Relapsing multiple…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis [Phase 2, Phase 3]
Clinical trial update for a Phase 2/Phase 3 study evaluating ublituximab in pediatric participants with relapsing forms of multiple sclerosi…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS) [Phase 3]
Phase 3 clinical trial to evaluate pharmacokinetics, pharmacodynamics, safety, radiological and clinical effects of subcutaneous ublituximab…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab [Phase 3]
A Phase 3 clinical trial evaluating a modified regimen of Ublituximab for relapsing multiple sclerosis, currently recruiting to assess safet…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
A Novartis-sponsored clinical trial is evaluating various injectable and oral treatments for relapsing multiple sclerosis and is currently r…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple Sclerosis [Phase 1, Phase 2]
An open-label Phase 1/2 clinical trial evaluating the safety, efficacy, and cellular kinetics of YTB323 in Relapsing Multiple Sclerosis is c…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of fenebrutinib versus teriflunomide in Relapsing Multiple Sclerosis; the stu…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS [Phase 3]
This entry reports an ongoing Phase 3 long-term study assessing the safety, tolerability, and effectiveness of ofatumumab in patients with r…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis [Phase 3]
This Phase 3 clinical trial update compares the pharmacokinetics, pharmacodynamics, efficacy, and safety of the proposed CYB704 ocrelizumab …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) [Phase 3]
A Phase 3 clinical trial comparing fenebrutinib with teriflunomide in relapsing multiple sclerosis is active but not recruiting.
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset [Phase 4]
The update summarizes a Phase 4 study evaluating the effects of ocrelizumab on cerebrospinal fluid biomarkers at the onset of multiple scler…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Exploring the Efficacy and Safety of Ofatumumab in Patients With Relapsing Multiple Sclerosis (RMS) and Its Impact on Serum Neurofilament Light Chain (sNfL) Levels
A clinical trial update describes ongoing recruitment to assess the efficacy and safety of ofatumumab in Relapsing multiple sclerosis and it…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Early Versus Late Ofatumumab (Kesimpta®) Use in Austrian RMS-Patients Over 2 Years
A clinical trial comparing early versus late use of Kesimpta (ofatumumab) in Austrian patients with relapsing multiple sclerosis, with the s…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: A Cross-sectional Study to Assess the Effectiveness and Safety of Ofatumumab (Kesimpta®) in Patients With Relapsing Multiple Sclerosis in the Spanish Clinical Practice
A cross-sectional real-world study assessing the effectiveness and safety of Kesimpta (ofatumumab) in patients with relapsing multiple scler…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Kesimpta (Ofatumumab) in Greek Multiple Sclerosis Patients - an Observational Study
An observational study evaluating Kesimpta (ofatumumab) in Greek patients with relapsing multiple sclerosis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone) [Phase 2]
MoonStone is a Phase 2 study of obexelimab for relapsing multiple sclerosis; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod [Phase 4]
A Phase 4 prospective study is evaluating sequencing of anti-CD20 therapies before starting Ozanimod in Relapsing Multiple Sclerosis, curren…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Exploring the Profiles of RMS Patients on Ofatumumab or Ocrelizumab in a Real-World Setting in the Gulf
A completed real-world study evaluating Relapsing Multiple Sclerosis patients treated with ofatumumab or ocrelizumab in the Gulf region.
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple Sclerosis [Phase 4]
A Phase 4 clinical trial evaluating the effectiveness and safety of Ozanimod in Chinese adults with relapsing multiple sclerosis; the study …